Sedation and analgesia are essential components of the day-to-day management of critically ill pediatric patients. Ketamine, an N-methyl-d-aspartate (NMDA) receptor antagonist, has been used for decades for its sedative and analgesic properties. In the pediatric intensive care unit (PICU), ketamine has been used for a variety of indications, commonly for procedural sedation. At subanesthetic doses, ketamine is also used for acute and chronic pain management, often as an adjunct to opioid or as an opioid-sparing agent. This chapter will discuss the pharmacology, indications, dosing, and side effects of ketamine, relevant to its use in the PICU.
CITATION STYLE
Wong, J. J. M., Yeo, A. S. H., Buang, S. N. H., & Chan, Y. H. (2021). Sedation and Analgesia for the Critically Ill Child: Ketamine. In Sedation and Analgesia for the Pediatric Intensivist (pp. 97–107). Springer International Publishing. https://doi.org/10.1007/978-3-030-52555-2_8
Mendeley helps you to discover research relevant for your work.